Risk factors for immune-related adverse events: what have we learned and what lies ahead?

Overview of attention for article published in Biomarker Research, November 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 37 publications that cite this research output.

37

The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.

Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study

Article in Supportive Care in Cancer (April 2024)

Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis

Article in Frontiers in Immunology (April 2024)

Comparative analysis of immunotherapy responses in small cell lung cancer patients with dermatomyositis

Article in Thoracic Cancer (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.